1.Institute for Functional Genomics(IGF),University of Montpellier,CNRS,INSERM,Montpellier,France.

2. Laboratory of Neurotherapies and Neuromodulation, Department of Clinical Neuroscience, Lausanne University Hospital,University of Lausanne,Lausanne,Switzerland.

3. Laboratory of Neurotherapies and Neuromodulation, Neuroscience Research Center, Lausanne University Hospital and University of Lausanne,Lausanne,Switzerland.

4. Neuroimmunology and Neurodegeneration Section, The Neuroscience and Rare Diseases Discovery and Translational Area,F.Hoffman-La Roche,Basel,Switzerland.

5. Edmond and Lily Safra Center for Brain Sciences,The Hebrew University of Jerusalem,Jerusalem,Israel.

6. Department of Neurology,Yale University School of Medicine,New Haven,Connecticut,USA.

7. Department of Neuroscience,Yale University School of Medicine,New Haven,Connecticut,USA.

8. Commissariat à l'Energie Atomique et aux Energies Alternatives, Département de la Recherche Fondamentale,Institut de Biologie Fran?ois Jacob,MIRCen,Fontenay-aux-Roses,France.

9. Centre National de la Recherche Scientifique, Neurodegenerative Diseases Laboratory, Université Paris-Sud,Université Paris-Saclay,UMR 9199,Fontenay-aux-Roses,France.

10. Program in Neurosciences and Mental Health, The Hospital for Sick Children, and Department of Molecular Genetics,The University of Toronto,Toronto,Canada.

摘 自 Glia.2020 68(9):1692-1728.doi: 10.1002/glia.23780.Epub 2020 Jan 20.